Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1818 of 6351
-
Freezing device could offer new hope for sleep apnea sufferers
Disease control OngoingThis is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in patients with moderate to severe OSA. The study will also evaluate the chronic perfo…
Sponsor: Cryosa, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Experimental gene therapy aims to halt vision loss in rare eye disease
Disease control OngoingThe purpose of the study is to assess the safety and tolerability of bilateral subretinal delivery of adeno-associated virus vector with a serotype 5 capsid human rhodopsin kinase promoter. retinitis pigmentosa guanosine triphosphatase regulator (AAV5-hRKp.RPGR).
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
App aims to boost motivation in schizophrenia patients
Symptom relief CompletedThe purpose of the proposed an open label extension (OLE) study is to evaluate the maintained efficacy and safety of a second consecutive course of Click Therapeutics Study App as an adjunct treatment to standard of care (SOC) in participants who were on the Study App and have re…
Phase 3 • Sponsor: Click Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New drug shows promise for Long-Term control of rare muscle disease
Disease control By invitation onlyThe main purpose of this study is to measure the long-term safety and tolerability of efgartigimod PH20 SC in adult participants with Idiopathic Inflammatory Myopathy (IIM) who previously participated in ARGX-113-2007. The study consists of a treatment period where participants …
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for advanced breast cancer: experimental drug FWD1802 enters human trials
Disease control Recruiting nowA Phase I/II, Open-label study to assess the safety, tolerability, pharmacokinetic, and antitumor efficacy of FWD1802 monotherapy in patients with ER+/HER2- unresectable locally advanced or metastatic breast cancer. This clinical trial aims to explore the role of FWD1802 in the E…
Phase 1/2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a 30-Year-Old blood vessel drug ease Parkinson's?
Symptom relief OngoingThe aim of this phase Ila trial is to provide evidence on safety, tolerability and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with early Parkinson's disease (PD). Fasudil has shown neuroprotective and pro-regenerative effects, modulated microglial activity and…
Phase 2 • Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Your favorite tunes might calm you during eye surgery
Symptom relief CompletedThis randomized controlled trial evaluated the effect of a personalized music intervention on anxiety and pain in patients undergoing cataract surgery under local anesthesia. A total of 100 patients were randomly assigned to an intervention group or a control group. Patients in t…
Sponsor: Ege University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Text message screening could catch perinatal depression early
Knowledge-focused OngoingThe MATTER project is a digital, community-based perinatal mental health screening and early intervention program implemented in primary care and hospital settings in the Alentejo region, Portugal. The project integrates automated digital screening pathways within the national el…
Sponsor: Universidade Nova de Lisboa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New scoring system aims to cut child deaths from malnutrition in chad
Disease control CompletedThe purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.
Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can mindfulness and diet ease the double burden on black women caregivers?
Disease control OngoingDue to health and wealth disparities, no demographic group is more at risk than African American women for the double jeopardy of stress from caregiving for persons living with dementia (PLWD) and stress associated with hypertension (HTN). This double jeopardy puts those they car…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New dosing strategy aims to make liver cancer drug easier to tolerate
Disease control OngoingThe present protocol (STRAT-aHCC trial) aims to prospectively evaluate the tolerability, quality of life and efficacy of an alternative regimen of regorafenib in patients with advanced hepatocellular carcinoma (HCC) after progression to first-line. Patients will receive increasin…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Spinal zap plus breathing drills may boost lung power after paralysis
Symptom relief Recruiting nowRespiratory complications are among the leading causes of death in patients with chronic spinal cord injury (SCI). Our previous work showed that pulmonary function can be improved by using our original respiratory training method. However, the effectiveness of this intervention i…
Sponsor: University of Louisville • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Artificial pancreas may protect hearts in type 1 diabetes
Disease control Recruiting nowThis study will examine the potential cardiovascular effect(s) of artificial pancreas (AP) technology in patients with type 1 diabetes. AP technology is a system of devices that closely mimics the glucose-regulating function of a healthy human pancreas. It includes an insulin pum…
Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Cuff therapy could boost brain recovery after hemorrhage
Disease control Recruiting nowThe goal of this clinical trial is to examine the effect of limb occlusion therapy (remote ischemic conditioning, RIC) in subjects with aneurysmal subarachnoid hemorrhage. The main question it aims to answer is whether RIC can improve long-term recovery in participants with aneu…
Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Beetroot juice boosts leg circulation in new PAD study
Symptom relief Recruiting nowSupervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/wee…
Phase 3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a special diet boost rectal cancer treatment?
Disease control Recruiting nowThis clinical study aims to assess feasibility, safety, tolerability, and compliance of a Nonessential Amino Acid Restriction (NEAAR) medical food in adult patients with locally advanced rectal cancer during standard of care short course radiotherapy followed by standard of care …
Sponsor: University of South Florida • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a new drug tame fatty liver disease? early trial aims to find out
Disease control Recruiting nowThis Phase 1 trial will explore the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple ascending doses of INI-822 in healthy volunteers in Parts A, B, D and F and in participants with a history of MASH or presumed MASH in Part C and in pa…
Phase 1 • Sponsor: Inipharm Australia Pty Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can botox doses be optimized for kids with cerebral palsy?
Disease control CompletedSpasticity is often observed as muscle tightness and stiffness in the upper and/or lower limbs. Upper limb spasticity can interfere with joint movement and its severity can range from mild to severe. This study will assess how effective OnabotulinumtoxinA is in treating pediatric…
Sponsor: AbbVie • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for stomach cancer patients with abdominal spread
Disease control Recruiting nowTo learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New antibody aims to shield kidneys from autoimmune attack
Disease control Recruiting nowThe goal of this clinical trial is to learn if a new drug that might help protect and preserve kidney function in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV). AAV is a type of autoimmune disease where the body's own immune system attacks itself, and in …
Phase 2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC